Vesalio, Inc

Vesalio, Inc is a medical device company specializing in mechanical thrombectomy systems for acute arterial occlusions across neurovascular, coronary, and peripheral vascular territories. The company manufactures a comprehensive platform of patented thrombectomy devices leveraging proprietary Drop Zone™ technology designed to maximize clot retention and first-pass recanalization success. Primary product lines include: NeVa (neurovascular stroke thrombectomy), NeVa NET (next-generation neurovascular system with integrated micro-filter), NeVa VS (post-aneurysmal subarachnoid hemorrhage cerebral vasospasm treatment), enVast (coronary thrombectomy for large thrombus burden), pVasc (peripheral arterial occlusion thrombectomy), and NeVaSC (aspiration catheter). The company holds multiple regulatory clearances including FDA 510(k) clearances for several product lines and CE marks for international markets. Vesalio addresses a significant clinical need across three major disease areas: ischemic stroke (approximately 15 million cases annually, 80% clot-related), acute myocardial infarction (8.5 million cases annually, 30% clot-related), and acute limb ischemia (2.5 million cases annually, 80% clot-related). The platform is supported by robust clinical evidence, with published cases and peer-reviewed data demonstrating high recanalization rates and clinical efficacy across multiple vascular territories.